Safety and Efficacy of the Extracorporeal Liver Assist Device (ELAD®) In Patients With Fulminant Hepatic Failure (FHF)

This study has been withdrawn prior to enrollment.

(To focus on another clinical indication.)

Sponsor:

Information provided by (Responsible Party):

Vital Therapies, Inc.

ClinicalTrials.gov Identifier:

NCT00832728

First received: January 29, 2009

Last updated: July 24, 2012

Last verified: July 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study was withdrawn before participants were enrolled.

Study Status:	This study has been withdrawn prior to enrollment.
Study Completion Date:	September 2011
Primary Completion Date:	September 2011 (Final data collection date for primary outcome measure)